GEN Exclusives

More »

GEN News Highlights

Back to Item »

Roche to Plug Over $181M Into Manufacturing Sites to Produce Self-Administration Device for Herceptin

Subcutaneous Herceptin formulation was developed using Halozyme technology and is undergoing Phase III trials.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Children and Antipsychotic Drugs

Do you think children and adolescents with behavioral problems are overmedicated?